Gilead Sciences, Inc. (GIS.DE) XETRA

101.46

+0.66(+0.65%)

Updated at August 18 05:35PM

Currency In EUR

Valuation

Market Cap115.69B
Enterprise Value132.41B
P/E Ratio23.31
PEG Ratio3.98
Price/Sales Ratio5.08
Price/Book Ratio7.48
Enterprise/Revenue5.77
Enterprise/EBITDA15.17

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin0.22
Operating Margin0.28

Management Effectiveness

Return On Assets0.11
Return On Equity0.33

Income Statement

Revenue28.75B
Revenue/Share23.18
Gross Profit22.5B
EBITDA4.43B
Net Income480M
Diluted EPS0.38

Balance Sheet

Total Cash11.57B
Total Cash/Share4.19
Total Debt26.71B
Total Debt/Equity1.27
Current Ratio1.32
Book Value Per Share15.74

Price History

52-Week Change50.8
52-Week High111.84
52-Week Low66.48
Moving Average 50 Days96.22
Moving Average 200 Days94.44

Statistics

Average Volume693
Shares Outstanding1.24B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate3.12
Trailing Annual Dividend Yield2.64
Payout Ratio0.63
Last Split Factor2:1
Last Split DateJanuary 28, 2013